Clinical Trial Update: SPI-1005 for the Treatment of Meniere's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SPI-1005 for Ménière's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ménière Disease

Drugs mentioned

• SPI-1005

Snippet

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Meniere Disease, Ménière | Phase 3 | Status: COMPLETED